Every open market buy and sale of Corcept Therapeutics Inc stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net sellers over the last 12 months: $3.3M bought and $98.4M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when CORT insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an CORT officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every CORT insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | James N WilsonDirector | Sale plan | 10,000 | $72.67 | $727K | 1,044,543 | Nov 17Form 4 |
| Nov 10, 2026 | Daniel N Swisher JRDirector | Sale plan | 1,500 | $74.07 | $111K | 0 | Nov 13Form 4 |
| Nov 3, 2026 | Sean MaduckSee Remarks | Sale plan | 25,000 | $81.85 | $2M | 9,938 | Nov 4Form 4 |
| Nov 2, 2026 | Roberto Wandenkolk VieiraPresident, Oncology | Sale plan | 8,333 | $80.89 | $674K | 3,946 | Nov 4Form 4 |
| Oct 15, 2026 | James N WilsonDirector | Sale plan | 10,000 | $114.81 | $1.1M | 1,054,543 | Oct 16Form 4 |
| Oct 2, 2026 | Sean MaduckSee Remarks | Sale plan | 25,000 | $116.26 | $2.9M | 9,938 | Oct 5Form 4 |
| Oct 2, 2026 | Joseph Douglas LyonSee Remarks | Sale plan | 10,000 | $116.07 | $1.2M | 5,683 | Oct 5Form 4 |
| Oct 2, 2026 | Roberto Wandenkolk VieiraPresident, Oncology | Sale plan | 8,333 | $116.10 | $967K | 3,946 | Oct 5Form 4 |
| Sep 16, 2026 | Roberto Wandenkolk VieiraPresident, Oncology | Sale plan | 296 | $100.82 | $30K | 3,946 | Sep 18Form 4 |
| Sep 15, 2026 | James N WilsonDirector | Sale plan | 10,000 | $110.69 | $1.1M | 1,064,543 | Sep 16Form 4 |
| Sep 14, 2026 | Joseph Douglas LyonSee Remarks | Sale plan | 10,000 | $113.49 | $1.1M | 5,683 | Sep 16Form 4 |
| Sep 2, 2026 | Roberto Wandenkolk VieiraPresident, Oncology | Sale plan | 58,333 | $110.76 | $6.5M | 4,242 | Sep 3Form 4 |
| Sep 1, 2026 | Sean MaduckSee Remarks | Sale plan | 25,000 | $114.43 | $2.9M | 9,755 | Sep 3Form 4 |
| Aug 26, 2026 | Kimberly ParkDirector | Sale | 26,685 | $122.55 | $3.3M | 0 | Aug 28Form 4 |
| Aug 25, 2026 | Sean MaduckSee Remarks | Sale plan | 30,955 | $125.58 | $3.9M | 9,755 | Aug 27Form 4 |
CORT insider trading FAQ
Are CORT insiders buying or selling?
Insiders are net sellers over the last 12 months. 1 insiders bought $3.3M of CORT on the open market in 1 trades, and 11 sold $98.4M in 51 trades, 93% of that under pre-arranged trading plans.
When did an CORT insider last buy shares?
G Leonard Baker Jr (Director) bought 100,000 shares for $3.3M on Mar 17, 2026, reported on Mar 19, 2026.
When did an CORT insider last sell shares?
James N Wilson (Director) sold 10,000 shares for $727K on Nov 13, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
